09/30/2024 3:29 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/26/2024 5:44 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 2:04 PM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024 7:01 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 4:21 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 5:32 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/13/2024 3:30 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:35 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:36 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:36 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:37 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 4:00 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/20/2024 5:29 AM | Kiromic BioPharma (Filer)
| Form ARS | |
05/10/2024 9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 4:29 PM | Kiromic BioPharma (Issuer) Mirandola Leonardo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 4:00 PM | BERSANI PIETRO (Filed by) Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024 5:17 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024 4:00 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024 4:58 PM | Catlin Michael (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:55 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:57 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 8:56 PM | Kiromic BioPharma (Subject) YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
01/11/2024 3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 9:25 AM | Empery Asset Management, LP (Filed by) Kiromic BioPharma (Subject)
| Form SC 13G/A | |
11/20/2023 7:46 AM | Kiromic BioPharma (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
11/09/2023 8:49 AM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |